One a duckhead, always a duckhead, especially when it comes to your BS at this MB . . . then again, what more could anyone expect from a stockprick?
you the same POS keyboard junkie who steals then blasts BS all over the Board? Tell us all: you ever owned a single GALE share? You're such a Farce from the moment you place your digits upon that keyboard - you're laughable! But I would genuinely Thank You to know you're actually Short a few GALE shares. Tell all, just how deep down that rabbit hole do your finances allow you to dwell?
this particular version of "free" is another example of stealing from a similar ID. This one, "freeinheoic" is a dead-weight basher ID most likely in use by any number of keyboard jocks grouped together in a Mumbai sweathouse and who (collectively) earn a couple of dollars equivalent per day as they bash away...... smelly and disgusting....
now this "hugo" character - this one stinks about as bad as can be...... no credibility, no brain, just a POS headliner basher. Probably makes a few Rupees per posting.....
Do you think that a man of his (Einhorn's) background, reputation, and knowledge (including "insider knowledge") would accept being issued Company Stock Options if, for a moment, he had any doubt whatsoever about the Integrity of that Company? Please don't be stupid, THINK.......
Gene: we don't want to get too far ahead of our selves.... About ten minutes ago when the Pre-Market "Ask" was at 2.13, it took only 300 shares (purchased) to cause the "Ask" to bounce to 2.25. I know because I was the one who bought those shares. In other words, all I see for this moment is a highly Volatile platform and that the Market Makers, while always willing to sell, are going to make Buyers pay a hefty premium??? Pre-Market is a Beast all to itself and is not necessarily an indicator of what the general trading session has to offer..... Just a note of caution. Dan
Interesting.... and you're right about the "record' date. But I have a difficult time "believing" that something as simple as just another posted record of PRESENT (this one at CliniclTrials-dot-gov) would stimulate or prompt added buying of GALE shares. ?? BTW and for what it is or isn't worth - I briefly "touched" the pre-market activity this morning and with a meager 300 shares purchased the "Ask" increased from 2.13 to 2.25. Looks to me as though we're going to see another day of Volatility with not necessarily much volume! The Market Makers aren't giving these shares away - they're going to make the Buyers pay! One way or another, it's likely to be an interesting session.....
'freeinheoic' - coming from you, a JUNKIE, I'm delighted with your "junk" perception. Wonderful that we're able to agree..... Thank you for your contribution....
Pin: My perception is that you're looking at the smoke rather than at the Substance! Are you, for example, aware of the increasing Abstral sales & that "ER" is fast approaching (no self-respecting Short would want to remain "vulnerable" just in case Q-1 net Abstral sales come in at much over $2.5MM)! Do you have any clue of what the Un-Blinding of Phase III NeuVax data is all about, when it occurs, and what the possible ramifications of this Un-Blinding might be? Are you aware of the nearly fully enrolled P-3 NeuVax Clinical Trials? While I strongly support your "Strong Buy" recommendation, Pin, just how much Galena data are you familiar with? I'm not asking to be impolite nor admonishing in any manner whatsoever. It's just that I often get the sense that many who "take a toss" at something such as GALE have, at best, only a limited concept of what's really going on within the Company. By the very nature of this logic, it is all too often those who are Less Informed (or worse yet, ILL-informed) who are the vulnerable targets of the Bashing & Fear mongering efforts and who repeatedly suffer the consequences of Unnecessary Losses. My best, Dan
Thank you, Bry: I sense that it's important we not allow the Bashers to dominate this Board. Most of them a nothing more than paid slingers of BS; they own not a single share; they have no Standing here. Notice how their strategy often involves Smoking Out as much of page one as possible - all in their distorted efforts to deceive, discredit, deny the truth, and to cause as much possible mayhem and Fear as possible. We need to recognize their tactics and we need to respond aggressively and as proactively as we're able. Thank you again, Bry.
Oh, with respect to the avi.morax "character," it's been a steady basher for the past 18 or so months. Certainly yet another reject likely being compensated in Rupees for its bashing activities......?
Fugitive: although it's been years since the era of my market-making activities, I may be mistaken but on a "technical" level, it used to be that stock was traded in Batches or in Lots or in Increments of 100 shares. It might well be that today's electronics allow the rapid display of the lots as they're actually processing through the system.?? For my part, and as I view Level II trades, I would hesitate coming to any conclusions about the size of the batches that cycle through your viewing screen.... All my "opinions" that you'll need to check further to establish "fact." Respectfully, Dan
Randy: you already know I'm at least 99% "with you"..... I've seen a few rays of hope when it comes to WG - enough for me to have been prompted to write as I did. Many of us (probably MOST of us) who contribute to this MB are about as Stubborn as humans are capable of being. As to why WG is as often compelled to Bash as he is - well, maybe some day he'll actually "explain" himself (this assumes he's a "real" person, not just another manifestation of those quick keyboard fingers emanating from a dingy sweatshop in India)? Let's see if leaving the door slightly open will allow WG to respond in a civil, conversational manner??? Be and Keep well, Dan
Great Cash Position
Increasing & successful Sales Revenues
NeuVax, NeuVax, NeuVax - from the standpoint of Oncology, NeuVax may well define the most exciting Cancer Adjuvant Treatment modality of the past 20+ years..... Important Un-Blinding of Phase III data are clearly in view
Phase III NeuVax Clinical Trials ongoing in 14 countries & at 150 clinical sites is about to be Fully Enrolled with over 700 participants.
Folate Binding Protein (focus on Ovarian Cancer Adjuvant Treatment) Ongoing as are several other ongoing Clincial Trials
Mills acquisition slated to yield initial results during 2014
I'm sure I've overlooked some aspects of the Company's momentum and potentials..... please feel free to contribute.
Yes, I am long a good batch of GALE shares (have been so since 2012).
Tadpole: my opinion is that we're seeing Buying ahead of the upcoming Abstral sales data (in about 2 weeks). Remember, there are more than 25 million GALE shares Short (as of NASDAQ official data of 3/31//14). Keep in mind today's actual Short data could just as easily reflect more (possibly fewer) short shares. Whatever the true Short numbers, millions of share need to be purchased by the Shorts. And they're quite savvy and they're fully aware we've most likely "Hit Bottom" for the foreseeable months of 2014 (IMO). Furthermore, we'll soon be reading about the FULLY ENROLLED Phase III NeuVax Trials (700 + participants). And more important than any other Fact is that NeuVax Phase III Clinical Data will (in the relatively near future) be Un-blinded and at which point in time this stock might surge in double-digits. If you've been doing your due diligence, you KNOW that NeuVax might soon translate into the most exciting Cancer Adjuvant Treatment modality of the past 20+ years. (I make my statements based upon Phase 2 NeuVax Clinical trials & the 60-month long data that CLEARLY identified NeuVax as a Highly Promising Adjuvant Treatment potential.) All of what I've stated herein is nothing more than publically available information. Yes, I am definitely LONG my GALE shares and have been such for the past 2 years. Respectfully, Dan
Nice try for a pathetic bashterized version of a humanoid such as you pretend to be while in fact you're nothing more than a Lying organism residing in Mumbai...... go earn your Rupees in a dignified manner........ Although you occupy space approximately half-way around the world's sphere (relative to my comfortable habitat in Denver, CO, USA), your stench is as succinct and obvious as are the words displayed here and now....
Oh, and while you're at it, the 'garycoopers' ID posts are misleading, inaccurate, and to be ignored. To the best of my knowledge, this recently-appearing ID is nothing more or less than a revision of any one of the Bashing IDs that have frequently popped up at this MB. Not to be taken "personally" nor "seriously," this new ID is simply doing its job in behalf of the Short Interests.... Dan
just another revision of a former ID. Paid to do what it does. Simple IGNORE
Anyone that seeks to minimize the FACT that NeuVax Phase III Clinical Data will SOON be Un-Blinded is not only a Liar, that idiot is attempting to perpetrate the worse sort of Mis-Information. Briefly, and per the clinical protocols established in collaborations by Galena & the FDA, there exists an FDA-established "independent committee" responsible for constant monitoring of NeuVax Phase III Clinical Data. When this Committee registers the "70th Recurrence" this same group is charged with the responsibility of Un-Blinding all of the Phase III NeuVax data, evaluating said data, and then issuing a report to the proper FDA authorities. The latter will then review the report and data issued by the Committee after which the FDA will communicate with the Company. The Company will follow-up with appropriate measures following its communications with the FDA.
So, is it possible that the FDA will give Galena "the NOD" to complete Phase III Trials? ABSOLUTELY and positively "YES." And should such a "Nod" be given by the FDA, does this "Nod" have important POSITIVE implications? Again, a Resounding "YES!"
Based upon Phase 2 NeuVax Clinical Data, and which positive clinical data forged the basis of Phase III protocols and for having the FDA issue NeuVax its "Special" status, it remains HIGHLY LIKELY that Phase III, Un-blinded data will be consistent with Phase 2 findings AND that NeuVax will be well on its way to enhancing the world of Adjuvant Cancer Immunological Treatments as has NEVER been accomplished before. And that, my friends, is REALLY BIG NEWS!!!! Huge, in fact!! Bottom Line: we will be receiving Important Phase 3 info in relatively Short Order - only several months from NOW!!!